HypoxamiR regulation and function in ischemic cardiovascular diseases

Antioxidants and Redox Signaling

Volumn 21, Issue 8, 2014, Pages 1202-1219

  Greco, Simona ^a   Gaetano, Carlo ^b   Martelli, Fabio ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCED MICRORNA; MICRORNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; BIOSYNTHESIS; CEREBROVASCULAR ACCIDENT; GENE CONTROL; GENE FUNCTION; GENE REGULATORY NETWORK; HEART INFARCTION; HUMAN; HYPOXIA; ISCHEMIC HEART DISEASE; OXYGEN CONSUMPTION; OXYGEN TENSION; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; STEM CELL TRANSPLANTATION; WOUND HEALING; ANIMAL; APOPTOSIS; CARDIOVASCULAR DISEASE; GENETICS; ISCHEMIA; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; RNA INTERFERENCE;

ANIMALS; APOPTOSIS; CARDIOVASCULAR DISEASES; HUMANS; ISCHEMIA; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; RNA INTERFERENCE;

EID: 84907324299     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5403     Document Type: Review

References (162)

1. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, Goto Y, Nonogi H, and Iwai N. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 56: 1183-1185, 2010
2. Aguado-Fraile E, Ramos E, Saenz-Morales D, Conde E, Blanco-Sanchez I, Stamatakis K, del Peso L, Cuppen E, Brune B, and Bermejo ML. miR-127 protects proximal tubule cells against ischemia/reperfusion: Identification of kinesin family member 3B as miR-127 target. PLoS One 7: E44305, 2012
3. Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Li Z, and Yang B. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 391: 73-77, 2010
4. Alaiti MA, Ishikawa M, Masuda H, Simon DI, Jain MK, Asahara T, and Costa MA. Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34 + cells enhances cell-mediated angiogenesis. J Cell Mol Med 16: 2413-2421, 2012
5. Anversa P, Kajstura J, Rota M, and Leri A. Regenerating new heart with stem cells. J Clin Invest 123: 62-70, 2013
6. Bauersachs J and Thum T. Biogenesis and regulation of cardiovascular microRNAs. Circ Res 109: 334-347, 2011
7. Bergeron M, Yu AY, Solway KE, Semenza GL, and Sharp FR. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 11: 4159-4170, 1999
8. Bindra RS, Gibson SL, Meng A, Westermark U, Jasin M, Pierce AJ, Bristow RG, Classon MK, and Glazer PM. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res 65: 11597-11604, 2005
9. Biswas S, Roy S, Banerjee J, Hussain SR, Khanna S, Meenakshisundaram G, Kuppusamy P, Friedman A, and Sen CK. Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci USA 107: 6976-6981, 2010
10. Bonventre JV. Pathophysiology of AKI: Injury and normal and abnormal repair. Contrib Nephrol 165: 9-17, 2010
11. Bosch-Marce M, Okuyama H, Wesley JB, Sarkar K, Kimura H, Liu YV, Zhang H, Strazza M, Rey S, Savino L, Zhou YF, McDonald KR, Na Y, Vandiver S, Rabi A, Shaked Y, Kerbel R, Lavallee T, and Semenza GL. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 101: 1310-1318, 2007
12. Bostjancic E, Zidar N, and Glavac D. MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers 27: 255-268, 2009
13. Brabletz S and Brabletz T. The ZEB/miR-200 feedback loop-A motor of cellular plasticity in Development and cancer?. EMBO Rep 11: 670-677, 2010
14. Bruning U, Cerone L, Neufeld Z, Fitzpatrick SF, Cheong A, Scholz CC, Simpson DA, Leonard MO, Tambuwala MM, Cummins EP, and Taylor CT. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol 31: 4087-4096, 2011
15. Bye A, Rosjo H, Aspenes ST, Condorelli G, Omland T, and Wisloff U. Circulating microRNAs and aerobic fitness-The HUNT-Study. PLoS One 8: E57496, 2013
16. Campbell IL. Cytokine-mediated inflammation, tumorigenesis, and disease-Associated JAK/STAT/SOCS signaling circuits in the CNS. Brain Res 48: 166-177, 2005
17. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, and Ragoussis J. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348, 2008
18. Carthew RW and Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 136: 642-655, 2009
19. Caruso P, MacLean MR, Khanin R, McClure J, Soon E, Southgate M, MacDonald RA, Greig JA, Robertson KE, Masson R, Denby L, Dempsie Y, Long L, Morrell NW, and Baker AH. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension Due to chronic hypoxia and monocrotaline. Arterioscler Thromb Vasc Biol 30: 716-723, 2010
20. Chacko SM, Khan M, Kuppusamy ML, Pandian RP, Varadharaj S, Selvendiran K, Bratasz A, Rivera BK, and Kuppusamy P. Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells. Am J Physiol 296: H1263-H1273, 2009
21. Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, and Loscalzo J. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab 10: 273-284, 2009
22. Chan YC, Khanna S, Roy S, and Sen CK. miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem 286: 2047-2056, 2011
23. Chan YC, Roy S, Huang Y, Khanna S, and Sen CK. The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway. J Biol Chem 287: 41032-41043, 2012
24. Chan YC, Roy S, Khanna S, and Sen CK. Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2. Arterioscler Thromb Vasc Biol 32: 1372-1382, 2012
25. Chang W, Lee CY, Park JH, Park MS, Maeng LS, Yoon CS, Lee MY, Hwang KC, and Chung YA. Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1. J Vet Sci 14: 69-76, 2013
26. Chen WY, Liu WJ, Zhao YP, Zhou L, Zhang TP, Chen G, and Shu H. Induction, modulation and potential targets of miR-210 in pancreatic cancer cells. Hepatobiliary Pancreat Dis Int 11: 319-324, 2012
27. Chen Z, Lai TC, Jan YH, Lin FM, Wang WC, Xiao H, Wang YT, Sun W, Cui X, Li YS, Fang T, Zhao H, Padmanabhan C, Sun R, Wang DL, Jin H, Chau GY, Huang HD, Hsiao M, and Shyy JY. Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. J Clin Invest 123: 1057-1067, 2013
28. Chen Z, Li Y, Zhang H, Huang P, and Luthra R. Hypoxiaregulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 29: 4362-4368, 2010
29. Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B, Zhuang J, and Zhang C. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-Apoptosis through its target PDCD4. Cardiovasc Res 87: 431-439, 2010
30. Cicchillitti L, Di Stefano V, Isaia E, Crimaldi L, Fasanaro P, Ambrosino V, Antonini A, Capogrossi MC, Gaetano C, Piaggio G, and Martelli F. Hypoxia-inducible factor 1-Alpha induces miR-210 in normoxic differentiating myoblasts. J Biol Chem 287: 44761-44771, 2012
31. Cifuentes D, Xue H, Taylor DW, Patnode H, Mishima Y, Cheloufi S, Ma E, Mane S, Hannon GJ, Lawson ND, Wolfe SA, and Giraldez AJ. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 328: 1694-1698, 2010
32. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, and Schroen B. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circulation 3: 499-506, 2010
33. Crosby ME, Kulshreshtha R, Ivan M, and Glazer PM. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res 69: 1221-1229, 2009
34. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M, Micheli B, Biglioli P, Achilli F, Martelli F, Maggiolini S, Marenzi G, Pompilio G, and Capogrossi MC. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31: 2765-2773, 2010
35. Dekanty A, Romero NM, Bertolin AP, Thomas MG, Leishman CC, Perez-Perri JI, Boccaccio GL, and Wappner P. Drosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxia. PLoS Genet 6: E1000994, 2010
36. Di Stefano V, Zaccagnini G, Capogrossi MC, and Martelli F. microRNAs as peripheral blood biomarkers of cardiovascular disease. Vasc Pharmacol 55: 111-118, 2011
37. Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer 2: 29, 2003
38. Du R, Sun W, Xia L, Zhao A, Yu Y, Zhao L, Wang H, Huang C, and Sun S. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS One 7: E30771, 2012
39. Fang J, Song XW, Tian J, Chen HY, Li DF, Wang JF, Ren AJ, Yuan WJ, and Lin L. Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 17: 410-423, 2012
40. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, and Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883, 2008
41. Fasanaro P, Greco S, Ivan M, Capogrossi MC, and Martelli F. microRNA: Emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther 125: 92-104, 2010
42. Fasanaro P, Greco S, Lorenzi M, Pescatori M, Brioschi M, Kulshreshtha R, Banfi C, Stubbs A, Calin GA, Ivan M, Capogrossi MC, and Martelli F. An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem 284: 35134-35143, 2009
43. Fasanaro P, Romani S, Voellenkle C, Maimone B, Capogrossi MC, and Martelli F. ROD1 is a seedless target gene of hypoxia-induced miR-210. PLoS One 7: E44651, 2012
44. Favaro E, Ramachandran A, McCormick R, Gee H, Blancher C, Crosby M, Devlin C, Blick C, Buffa F, Li JL, Vojnovic B, Pires das Neves R, Glazer P, Iborra F, Ivan M, Ragoussis J, and Harris AL. MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One 5: E10345, 2010
45. Fiedler J, Jazbutyte V, Kirchmaier BC, Gupta SK, Lorenzen J, Hartmann D, Galuppo P, Kneitz S, Pena JT, Sohn-Lee C, Loyer X, Soutschek J, Brand T, Tuschl T, Heineke J, Martin U, Schulte-Merker S, Ertl G, Engelhardt S, Bauersachs J, and Thum T. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 124: 720-730, 2011
46. Fiedler J and Thum T. MicroRNAs in myocardial infarction. Arterioscler Thromb Vasc Biol 33: 201-205, 2013
47. Gao W, Xu J, Liu L, Shen H, Zeng H, and Shu Y. A systematic-Analysis of predicted miR-21 targets identifies a signature for lung cancer. Biomed Pharmacother 66: 21-28, 2012
48. Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, Basi D, Chandrashekhar YS, Hall JL, Roy S, Zeng Y, and Ramakrishnan S. Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-Alpha isoforms and promotes angiogenesis. J Clin Invest 120: 4141-4154, 2010
49. Giannakakis A, Sandaltzopoulos R, Greshock J, Liang S, Huang J, Hasegawa K, Li C, O"Brien-Jenkins A, Katsaros D, Weber BL, Simon C, Coukos G, and Zhang L. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther 7: 255-264, 2008
50. Gidlof O, Andersson P, van Der Pals J, Gotberg M, and Erlinge D. Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 118: 217-226, 2011
51. Gou D, Ramchandran R, Peng X, Yao L, Kang K, Sarkar J, Wang Z, Zhou G, and Raj JU. miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle cells during hypoxia. Am J Physiol Lung Cell Mol Physiol 303: L682-L691, 2012
52. Greco S, Fasanaro P, Castelvecchio S, D'Alessandra Y, Arcelli D, Di Donato M, Malavazos A, Capogrossi MC, Menicanti L, and Martelli F. MicroRNA dysregulation in Diabetic ischemic heart failure patients. Diabetes 61: 1633-1641, 2012
53. Grieger JC and Samulski RJ. Adeno-Associated virus vectorology, manufacturing, and clinical applications. Methods Enzymol 507: 229-254, 2012
54. Grosso S, Doyen J, Parks SK, Bertero T, Paye A, Cardinaud B, Gounon P, Lacas-Gervais S, Noel A, Pouyssegur J, Barbry P, Mazure NM, and Mari B. MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis 4: E544, 2013
55. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, and Bondesson M. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9: 617-628, 2005
56. Hata A. Functions of microRNAs in cardiovascular biology and disease. Annu Rev Physiol 75: 69-93, 2013
57. He J, Wu J, Xu N, Xie W, Li M, Li J, Jiang Y, Yang BB, and Zhang Y. MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genes. Nucleic Acids Res 41: 498-508, 2013
58. Ho JJ, Metcalf JL, Yan MS, Turgeon PJ, Wang JJ, Chalsev M, Petruzziello-Pellegrini TN, Tsui AK, He JZ, Dhamko H, Man HS, Robb GB, Teh BT, Ohh M, and Marsden PA. Functional importance of Dicer protein in the adaptive cellular response to hypoxia. J Biol Chem287: 29003-29020, 2012
59. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, Robbins RC, and Wu JC. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122: S124-S131, 2010
60. Huang F, Tang L, Fang ZF, Hu XQ, Pan JY, and Zhou SH. miR-1-mediated induction of cardiogenesis in mesenchymal stem cells via downregulation of Hes-1. Biomed Res Int 2013: 216286, 2013
61. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, Story M, Le QT, and Giaccia AJ. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 35: 856-867, 2009
62. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, and Kaelin WG Jr. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292: 464-468, 2001
63. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van Der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, and Hodges MR. Treatment of HCV infection by targeting microRNA. N Engl J Med 368: 1685-1694, 2013
64. Jiang X, Tsitsiou E, Herrick SE, and Lindsay MA. Micro-RNAs and the regulation of fibrosis. FEBS J 277: 2015-2021, 2010
65. Kane NM, Meloni M, Spencer HL, Craig MA, Strehl R, Milligan G, Houslay MD, Mountford JC, Emanueli C, and Baker AH. Derivation of endothelial cells from human embryonic stem cells by directed differentiation: Analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler ThrombVasc Biol 30: 1389-1397, 2013
66. Kang SG, Lee WH, Lee YH, Lee YS, and Kim SG. Hypoxiainducible factor-1alpha inhibition by a pyrrolopyrazine metabolite of oltipraz as a consequence of microRNAs 199a-5p and 20a induction. Carcinogenesis 33: 661-669, 2012
67. Katare R, Riu F, Mitchell K, Gubernator M, Campagnolo P, Cui Y, Fortunato O, Avolio E, Cesselli D, Beltrami AP, Angelini G, Emanueli C, and Madeddu P. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 109: 894-906, 2011
68. Kelly TJ, Souza AL, Clish CB, and Puigserver P. A hypoxiainduced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol Cell Biol 31: 2696-2706, 2011
69. Kim HW, Haider HK, Jiang S, and Ashraf M. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-Associated protein 2. J Biol Chem 284: 33161-33168, 2009
70. Kim HW, Jiang S, Ashraf M, and Haider KH. Stem cellbased delivery of Hypoxamir-210 to the infarcted heart: Implications on stem cell survival and preservation of infarcted heart function. J Mol Med (Berl) 90: 997-1010, 2012
71. Kim JH, Park SG, Song SY, Kim JK, and Sung JH. Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2. Cell Death Dis 4: E588, 2013
72. Kim VN, Han J, and Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10: 126-139, 2009
73. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, Davuluri R, Liu CG, Croce CM, Negrini M, Calin GA, and Ivan M. A microRNA signature of hypoxia. Mol Cell Biol 27: 1859-1867, 2007
74. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, Watanabe S, Baba O, Kojima Y, Shizuta S, Imai M, Tamura T, Kita T, and Kimura T. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circulation 4: 446-454, 2011
75. Latronico MV and Condorelli G. microRNAs in hypertrophy and heart failure. Exp Biol Med (Maywood) 236: 125-131, 2011
76. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, and Thistlethwaite PA. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342: 626-633, 2000
77. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, and Kim VN. MicroRNA genes are transcribed by RNA polymerase II. Embo J 23: 4051-4060, 2004
78. Li T, Cao H, Zhuang J, Wan J, Guan M, Yu B, Li X, and Zhang W. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta 412: 66-70, 2011
79. Liang WC, Wang Y, Wan DC, Yeung VS, and Waye MM. Characterization of miR-210 in 3T3-L1 adipogenesis. J Cell Biochem 114: 2699-2707, 2013
80. Liu F, Lou YL, Wu J, Ruan QF, Xie A, Guo F, Cui SP, Deng ZF, and Wang Y. Upregulation of microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/perfusion injury in vivo and in vitro. Kidney Blood Press Res 35: 182-191, 2012
81. Liu N and Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 18: 510-525, 2010
82. Liu W, Wen Y, Bi P, Lai X, Liu XS, Liu X, and Kuang S. Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation. Development 139: 2857-2865, 2012
83. Logue SE, Gustafsson AB, Samali A, and Gottlieb RA. Ischemia/reperfusion injury at the intersection with cell death. J Mol Cell Cardiol 38: 21-33, 2005
84. Loor G and Schumacker PT. Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ 15: 686-690, 2008
85. Lorenzen JM, Kielstein JT, Hafer C, Gupta SK, Kumpers P, Faulhaber-Walter R, Haller H, Fliser D, and Thum T. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 6: 1540-1546, 2011
86. Loscalzo J. Harrison's Cardiovascular Medicine. New York: McGraw-Hill Medical, 2010
87. Lou Y, Gao F, Xie A, Guo F, Deng Z, and Wang Y. [MicroRNA-210 modified human umbilical vein endothelial cells induce capillary formation]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 26: 587-591, 2012
88. Lou YL, Guo F, Liu F, Gao FL, Zhang PQ, Niu X, Guo SC, Yin JH, Wang Y, and Deng ZF. miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia. Mol Cell Biochem 370: 45-51, 2012
89. Lu TX, Munitz A, and Rothenberg ME. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol 182: 4994-5002, 2009
90. Madhyastha R, Madhyastha H, Nakajima Y, Omura S, and Maruyama M. MicroRNA signature in Diabetic wound healing: Promotive role of miR-21 in fibroblast migration. Int Wound J 9: 355-361, 2012
91. Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G, Antonini A, Martelli F, and Capogrossi MC. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ 18: 1628-1639, 2011
92. Mahon PC, Hirota K, and Semenza GL. FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15: 2675-2686, 2001
93. Majmundar AJ, Skuli N, Mesquita RC, Kim MN, Yodh AG, Nguyen-McCarty M, and Simon MC. O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling. Mol Cell Biol 32: 36-49, 2012
94. Majmundar AJ, Wong WJ, and Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40: 294-309, 2010
95. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, and Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275, 1999
96. Meng S, Cao J, Wang L, Zhou Q, Li Y, Shen C, Zhang X, and Wang C. MicroRNA 107 partly inhibits endothelial progenitor cells differentiation via HIF-1beta. PLoS One 7: E40323, 2012
97. Mizuno Y, Tokuzawa Y, Ninomiya Y, Yagi K, Yatsuka-Kanesaki Y, Suda T, Fukuda T, Katagiri T, Kondoh Y, Amemiya T, Tashiro H, and Okazaki Y. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett 583: 2263-2268, 2009
98. Muralimanoharan S, Maloyan A, Mele J, Guo C, Myatt LG, and Myatt L. MIR-210 modulates mitochondrial respiration in placenta with preeclampsia. Placenta 33: 816-823, 2012
99. Mutharasan RK, Nagpal V, Ichikawa Y, and Ardehali H. microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- And p53-dependent pathways and exerts cytoprotective effects. Am J Physiol 301: H1519-H1530, 2011
100. Olivieri F, Antonicelli R, Lorenzi M, D'Alessandra Y, Lazzarini R, Santini G, Spazzafumo L, Lisa R, La Sala L, Galeazzi R, Recchioni R, Testa R, Pompilio G, Capogrossi MC, and Procopio AD. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol 167: 531-536, 2013
101. Ong SG and Hausenloy DJ. Hypoxia-inducible factor as a therapeutic target for cardioprotection. Pharmacol Ther 136: 69-81, 2012
102. Ota H, Eto M, Kano MR, Kahyo T, Setou M, Ogawa S, Iijima K, Akishita M, and Ouchi Y. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler Thromb Vasc Biol 30: 2205-2211, 2010
103. Parikh VN, Jin RC, Rabello S, Gulbahce N, White K, Hale A, Cottrill KA, Shaik RS, Waxman AB, Zhang YY, Maron BA, Hartner JC, Fujiwara Y, Orkin SH, Haley KJ, Barabasi AL, Loscalzo J, and Chan SY. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: Results of a network bioinformatics approach. Circulation 125: 1520-1532, 2012
104. Pastar I, Khan AA, Stojadinovic O, Lebrun EA, Medina MC, Brem H, Kirsner RS, Jimenez JJ, Leslie C, and Tomic-Canic M. Induction of specific microRNAs inhibits cutaneous wound healing. J Biol Chem 287: 29324-29335, 2012
105. Peach G, Griffin M, Jones KG, Thompson MM, and Hinchliffe RJ. Diagnosis and management of peripheral arterial disease. BMJ 345: E5208, 2012
106. Poller W, Hajjar R, Schultheiss HP, and Fechner H. Cardiac-Targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure. Cardiovasc Res 86: 353-364, 2010
107. Potente M and Dimmeler S. Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 7: 2117-2122, 2008
108. Prabhakar NR and Semenza GL. Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev 92: 967-1003, 2012
109. Puissegur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K, Maurin T, Lebrigand K, Cardinaud B, Hofman V, Fourre S, Magnone V, Ricci JE, Pouyssegur J, Gounon P, Hofman P, Barbry P, and Mari B. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ 18: 465-478, 2011
110. Pulkkinen K, Malm T, Turunen M, Koistinaho J, and Yla-Herttuala S. Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett 582: 2397-2401, 2008
111. Qi HH, Ongusaha PP, Myllyharju J, Cheng D, Pakkanen O, Shi Y, Lee SW, Peng J, and Shi Y. Prolyl 4-hydroxylation regulates Argonaute 2 stability. Nature 455: 421-424, 2008
112. Qiao A, Khechaduri A, Kannan Mutharasan R, Wu R, Nagpal V, and Ardehali H. MicroRNA-210 decreases heme levels by targeting ferrochelatase in cardiomyocytes. J Am Heart Assoc 2: E000121, 2013
113. Qin L, Chen Y, Niu Y, Chen W, Wang Q, Xiao S, Li A, Xie Y, Li J, Zhao X, He Z, and Mo D. A deep investigation into the adipogenesis mechanism: Profile of microRNAs regulating adipogenesis by modulating the canonical Wnt/ beta-catenin signaling pathway. BMC Genomics 11: 320, 2010
114. Quiat D and Olson EN. MicroRNAs in cardiovascular disease: From pathogenesis to prevention and treatment. J Clin Invest 123: 11-18, 2013
115. Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 122: 4306-4313, 2012
116. Raitoharju E, Lyytikainen LP, Levula M, Oksala N, Mennander A, Tarkka M, Klopp N, Illig T, Kahonen M, Karhunen PJ, Laaksonen R, and Lehtimaki T. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 219: 211-217, 2011
117. Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, Vatner DE, Vatner SF, and Abdellatif M. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 104: 879-886, 2009
118. Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, and Sen CK. MicroRNA expression in response to murine myocardial infarction: MiR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 82: 21-29, 2009
119. Roy S and Sen CK. miRNA in wound inflammation and angiogenesis. Microcirculation 19: 224-232, 2012
120. Salloum FN, Yin C, and Kukreja RC. Role of microRNAs in cardiac preconditioning. J Cardiovasc Pharmacol 56: 581-588, 2010
121. Sarkar J, Gou D, Turaka P, Viktorova E, Ramchandran R, and Raj JU. MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol 299: L861-L871, 2010
122. Sayed D, He M, Hong C, Gao S, Rane S, Yang Z, and Abdellatif M. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem 285: 20281-20290, 2010
123. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, and Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-Alpha prolyl hydroxylase. Cancer Cell 7: 77-85, 2005
124. Semenza GL. Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med 2: 336-361, 2010
125. Semenza GL. Oxygen sensing, homeostasis, and disease. N Engl J Med 365: 537-547, 2011
126. Sen CK and Roy S. OxymiRs in cutaneous development, wound repair and regeneration. Semin Cell Dev Biol 23: 971-980, 2012
127. Sheedy FJ and O'Neill LA. Adding fuel to fire: MicroRNAs as a new class of mediators of inflammation. Ann Rheum Dis 67(Suppl 3): Iii50-iii55, 2008
128. Small EM, Frost RJ, and Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation 121: 1022-1032, 2010
129. Small EM and Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature 469: 336-342, 2011
130. So AY, Jung JW, Lee S, Kim HS, and Kang KS. DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs. PLoS One 6: E19503, 2011
131. Tabuchi T, Satoh M, Itoh T, and Nakamura M. MicroRNA-34a regulates the longevity-Associated protein SIRT1 in coronary artery disease: Effect of statins on SIRT1 and microRNA-34a expression. Clin Sci (Lond) 123: 161-171, 2012
132. Taguchi A, Yanagisawa K, Tanaka M, Cao K, Matsuyama Y, Goto H, and Takahashi T. Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res 68: 5540-5545, 2008
133. Terrell AM, Crisostomo PR, Wairiuko GM, Wang M, Morrell ED, and Meldrum DR. Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock 26: 226-234, 2006
134. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J, Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J, and Engelhardt S. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984, 2008
135. Tijsen AJ, Pinto YM, and Creemers EE. Circulating micro-RNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol 303: H1085-H1095, 2012
136. Tsuchiya S, Fujiwara T, Sato F, Shimada Y, Tanaka E, Sakai Y, Shimizu K, and Tsujimoto G. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem 286: 420-428, 2011
137. van Rooij E and Olson EN. MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles. Nat Rev Drug Discov 11: 860-872, 2012
138. Voellenkle C, Rooij J, Guffanti A, Brini E, Fasanaro P, Isaia E, Croft L, David M, Capogrossi MC, Moles A, Felsani A, and Martelli F. Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs. RNA 18: 472-484, 2012
139. Wang F, Xiong L, Huang X, Zhao T, Wu LY, Liu ZH, Ding X, Liu S, Wu Y, Zhao Y, Wu K, Zhu LL, and Fan M. miR-210 suppresses BNIP3 to protect against the apoptosis of neural progenitor cells. Stem Cell Res 11: 657-667, 2013
140. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, and Jing Q. Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31: 659-666, 2010
141. Wang H, Bian S, and Yang CS. Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha. Carcinogenesis 32: 1881-1889, 2011
142. Wang K, Long B, Jiao JQ, Wang JX, Liu JP, Li Q, and Li PF. miR-484 regulates mitochondrial network through targeting Fis1. Nat Commun 3: 781, 2012
143. Wang T, Zhang L, Shi C, Sun H, Wang J, Li R, Zou Z, Ran X, and Su Y. TGF-beta-induced miR-21 negatively regulates the antiproliferative activity but has no effect on EMT of TGF-beta in HaCaT cells. Int J Biochem Cell Biol 44: 366-376, 2012
144. Wiener CM, Booth G, and Semenza GL. In vivo expression of mRNAs encoding hypoxia-inducible factor 1. Biochem Biophys Res Commun 225: 485-488, 1996
145. Wu C, So J, Davis-Dusenbery BN, Qi HH, Bloch DB, Shi Y, Lagna G, and Hata A. Hypoxia potentiates microRNAmediated gene silencing through posttranslational modification of Argonaute2. Mol Cell Biol 31: 4760-4774, 2011
146. Xia Y, Choi HK, and Lee K. Recent advances in hypoxiainducible factor (HIF)-1 inhibitors. Eur J Med Chem 49: 24-40, 2012
147. Xiao F, Qiu H, Zhou L, Shen X, Yang L, and Ding K. WSS25 inhibits Dicer, downregulating microRNA-210, which targets Ephrin-A3, to suppress human microvascular endothelial cell (HMEC-1) tube formation. Glycobiology 23: 524-535, 2013
148. Xu Q, Seeger FH, Castillo J, Iekushi K, Boon RA, Farcas R, Manavski Y, Li YG, Assmus B, Zeiher AM, and Dimmeler S. Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease. J Am Coll Cardiol 59: 2107-2117, 2012
149. Xu WH, Yao XY, Yu HJ, Huang JW, and Cui LY. Downregulation of miR-199a may play a role in 3-nitropropionic acid induced ischemic tolerance in rat brain. Brain Res 1429: 116-123, 2012
150. Xu X, Kriegel AJ, Liu Y, Usa K, Mladinov D, Liu H, Fang Y, Ding X, and Liang M. Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney Int 82: 1167-1175, 2012
151. Yamakuchi M, Lotterman CD, Bao C, Hruban RH, Karim B, Mendell JT, Huso D, and Lowenstein CJ. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 107: 6334-6339, 2010
152. Yamasaki K, Nakasa T, Miyaki S, Yamasaki T, Yasunaga Y, and Ochi M. Angiogenic microRNA-210 is present in cells surrounding osteonecrosis. J Orthop Res 30: 1263-1270, 2012
153. Yang S, Banerjee S, Freitas A, Cui H, Xie N, Abraham E, and Liu G. miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 302: L521-L529, 2012
154. Yang W, Sun T, Cao J, Liu F, Tian Y, and Zhu W. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp Cell Res 318: 944-954, 2012
155. Yang X, Wang J, Guo SL, Fan KJ, Li J, Wang YL, Teng Y, and Yang X. miR-21 promotes keratinocyte migration and re-epithelialization During wound healing. Int J Biol Sci 7: 685-690, 2011
156. Yeo JH and Chong MM. Many routes to a micro RNA. IUBMB Life 63: 972-978, 2011
157. Ying Q, Liang L, Guo W, Zha R, Tian Q, Huang S, Yao J, Ding J, Bao M, Ge C, Yao M, Li J, and He X. Hypoxiainducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology 54: 2064-2075, 2011
158. Zaccagnini G,Maimone B, Di Stefano V, Fasanaro P, Greco S, Perfetti A, Capogrossi MC, Gaetano C, and Martelli F. Hypoxia-induced miR-210 modulates tissue response to acute peripheral ischemia. Antioxid Redox Signal 21: 1177-1188, 2014
159. Zeng L, Liu J, Wang Y, Wang L, Weng S, Tang Y, Zheng C, Cheng Q, Chen S, and Yang GY. MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia. Front Biosci (Elite Ed) 3: 1265-1272, 2011
160. Zhang Y, Zhang L, Chu W, Wang B, Zhang J, Zhao M, Li X, Li B, Lu Y, Yang B, and Shan H. Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes. Cell Physiol Biochem 26: 991-998, 2010
161. Zhang Z, Sun H, Dai H, Walsh RM, Imakura M, Schelter J, Burchard J, Dai X, Chang AN, Diaz RL, Marszalek JR, Bartz SR, Carleton M, Cleary MA, Linsley PS, and Grandori C. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8: 2756-2768, 2009
162. Zheng G, Tao Y, Yu W, and Schwartz RJ. SRF dependent Mir-210 silencing of the sonic hedgehog signaling pathway during cardiopoesis. Stem Cells 2013 DOI: 10.1002/ stem.1464